While neuromelanin has been shown to interact with and influence α-synuclein-associated toxicity, it remains to be investigated whether it also interacts with other PD genetic risk factors, such as leucine-rich repeat kinase 2 (LRRK2), PTEN-induced kinase 1 (PINK1), and Parkin. This evidence concerns the gene LRRK2 and Parkinson disease.